ArticleNeoplasia (New York, N.Y.)2014

Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors: suggestion of combination therapy.

Robert Torka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.